A Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMBD-501 in Patients With HER3-Expressing Solid Tumors
for
Melanoma (Skin), Non Small Cell Lung Cancer, Breast Cancer
Location: Farmington Hills MI, Indianapolis IN, Dallas TX,
Sponsor: Hummingbird Bioscience
Sex: All
Age: 18+
Code: NCT06956690
Phase1, Phase2, Recruiting
A Study of MGC028 in Participants With Advanced Solid Tumors